This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
Macquarie (MIC) Lags Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Macquarie (MIC) delivered earnings and revenue surprises of -12.62% and -3.96%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Top Ranked Income Stocks to Buy for December 31st
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, December 31st
7 Amazing Dividend Stocks to Buy for Secure Income in 2020
by Urmimala Biswas
The prospects of dividend stocks appear bright for 2020, making the following companies attractive bets.
5 High-Yield Dividend Stocks Up More Than 30% This Year
by Sreyoshi Mukherjee
As dividend growth investment gains popularity among investors, let's take a look at a few stocks worth investing.
Top Ranked Value Stocks to Buy for December 23rd
by Zacks Equity Research
Here are four stocks with buy rank and strong value characteristics for investors to consider today, December 23rd
GE to Offer Onshore Wind Turbine Solution to Rio Energy
by Zacks Equity Research
General Electric's (GE) onshore wind turbine solution - Cypress platform - is likely to make Rio Energy's Serra da Babilonia wind farm more efficient in producing renewable energy in Brazil.
Honeywell Buys Rebellion, Boosts Gas Monitoring Portfolio
by Zacks Equity Research
Honeywell's (HON) acquisition of Rebellion Photonics will enable it to enhance its portfolio of automation, process technologies and gas detection solutions.
General Electric's Aviation Unit Receives Contract From Aerion
by Zacks Equity Research
General Electric's (GE) aviation unit receives contract to provide electric power system to Aerion's AS2 supersonic business jet. This contract strengthens business relationship between the two parties.
Here's Why Investors Should Consider Buying ITT Stock Now
by Zacks Equity Research
ITT is likely to gain from the diversified business portfolio, innovation investments, shareholder-friendly policies, operational execution and acquired assets.
3M to Divest Drug Delivery Business to Altaris Capital Unit
by Zacks Equity Research
The divestment of 3M's (MMM) drug delivery business will enable the company to focus more on core health care business. This will also lead to a gain of 45 cents to 50 cents per share.